Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jian-Jun Xi, Yu Cao, Ruo-Yu He, Jian-Kang Zhang, Yan-Mei Zhao, Qiao Tong, Jian-Feng Bao, Yi-Chen Dong, Rang-Xiao Zhuang, Jin-Song Huang, Yongping Chen & Shou-Rong Liu. (2023) Design, Synthesis and Biological Evaluation of Glycosylated Derivatives of Silibinin as Potential Anti-Tumor Agents. Drug Design, Development and Therapy 17, pages 2063-2076.
Read now
Read now
Hua Nie, Bo Qiu, Qi-Xuan Yang, Ying Zhao, Xiao-Min Liu, Ying-Ting Zhang, Fu-Lin Liao & Sheng-Yuan Zhang. (2021) Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting in vivo. Journal of Liposome Research 31:1, pages 79-89.
Read now
Read now
Soumaye Amirsaadat, Younes Pilehvar-Soltanahmadi, Faraz Zarghami, Shahriar Alipour, Zohreh Ebrahimnezhad & Nosratollah Zarghami. (2017) Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells. Artificial Cells, Nanomedicine, and Biotechnology 45:8, pages 1649-1656.
Read now
Read now
Faiyaz Shakeel & Md Khalid Anwer. (2015) Dissolution thermodynamics and solubility of silymarin in PEG 400-water mixtures at different temperatures. Drug Development and Industrial Pharmacy 41:11, pages 1819-1823.
Read now
Read now
Pushpendra Kumar Jain, Murlidhar Kharya & Asmita Gajbhiye. (2013) Pharmacological evaluation of mangiferin herbosomes for antioxidant and hepatoprotection potential against ethanol induced hepatic damage. Drug Development and Industrial Pharmacy 39:11, pages 1840-1850.
Read now
Read now
Bohong Guo, Yi Cheng, Niying Li, Xiaofang Li, Miaozhen Jin, Ting Li & Jin Li. (2013) In vitro and in vivo studies of galactose-modified liver-targeting liposomes. Journal of Drug Targeting 21:3, pages 257-264.
Read now
Read now
Giuseppe Trapani, Nunzio Denora, Adriana Trapani & Valentino Laquintana. (2012) Recent advances in ligand targeted therapy. Journal of Drug Targeting 20:1, pages 1-22.
Read now
Read now
Articles from other publishers (16)
Baofei Yan, Xian Zheng, Yun Wang, Jingwen Yang, Xingyu Zhu, Mengmeng Qiu, Kexin Xia, Yongan Wang, Mian Li, Sipan Li, Xinai Ma, Jianjun Xie, Fengtao Li, Tingming Fu & Wei Li. (2023) Liposome-Based Silibinin for Mitigating Nonalcoholic Fatty Liver Disease: Dual Effects via Parenteral and Intestinal Routes. ACS Pharmacology & Translational Science 6:12, pages 1909-1923.
Crossref
Crossref
Zijian Dai, Yiyun Zhang, Yantong Meng, Siqi Li, Zhuoma Suonan, Yuge Sun, Junfu Ji, Qun Shen, Hao Zheng & Yong Xue. (2023) Targeted delivery of nutraceuticals derived from food for the treatment of obesity and its related complications. Food Chemistry 418, pages 135980.
Crossref
Crossref
V. Dhawan, A. Lokras, G. Joshi, M. Marwah, M. Venkatraman, B. Mohanty, K. Darshan, P. Chaudhari, U. Warawdekar, M. Saraf & M. Nagarsenker. (2022) Polysaccharide and monosaccharide guided liver delivery of Sorafenib Tosylate – A nano-strategic approach and comparative assessment of hepatospecificity. International Journal of Pharmaceutics 625, pages 122039.
Crossref
Crossref
Václav Tvrdý, Jana Pourová, Eduard Jirkovský, Vladimír Křen, Kateřina Valentová & Přemysl Mladěnka. (2021) Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin. Medicinal Research Reviews 41:4, pages 2195-2246.
Crossref
Crossref
Zhijun Yang. 2021. Novel Drug Delivery Systems for Chinese Medicines. Novel Drug Delivery Systems for Chinese Medicines
153
173
.
Wujin Sun, Jinqiang Wang, Quanyin HuXingwu ZhouAli Khademhosseini & Zhen Gu. (2020) CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation. Science Advances 6:21.
Crossref
Crossref
Milad Ashrafizadeh, Zahra Ahmadi, Reza Mohammadinejad, Tahereh Farkhondeh & Saeed Samarghandian. (2020) Nano-soldiers Ameliorate Silibinin Delivery: A Review Study. Current Drug Delivery 17:1, pages 15-22.
Crossref
Crossref
Jing Zhang, Xiang Li & Leaf Huang. (2020) Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment. Advanced Drug Delivery Reviews 154-155, pages 245-273.
Crossref
Crossref
Devesh Kapoor, Shailendra Bhatt, Manish Kumar, Rahul Maheshwari & Rakesh K. Tekade. 2019. Basic Fundamentals of Drug Delivery. Basic Fundamentals of Drug Delivery
307
342
.
Sergey V. Lutsenko, Tatiana I. Gromovykh, Ivan I. KrasnyukJrJr, Ivan A. Vasilenko & Nataliya B. Feldman. (2018) Antihepatotoxic Activity of Liposomal Silibinin. BioNanoScience 8:2, pages 581-586.
Crossref
Crossref
Ying Li & Chunyan Zhu. (2016) Enhanced hepatic-targeted delivery via oral administration using nanoliposomes functionalized with a novel DSPE–PEG–cholic acid conjugate. RSC Advances 6:33, pages 28110-28120.
Crossref
Crossref
Xiaodan Zhou & Zhipeng Chen. (2015) Preparation and performance evaluation of emulsomes as a drug delivery system for silybin. Archives of Pharmacal Research 38:12, pages 2193-2200.
Crossref
Crossref
Usama Ahmad, Md Faiyazuddin, Md Talib Hussain, Sarfaraz Ahmad, Thamir M Alshammari & Faiyaz Shakeel. (2015) Silymarin: an insight to its formulation and analytical prospects. Acta Physiologiae Plantarum 37:11.
Crossref
Crossref
Kunwoo Lee, Mohammad Rafi, Xiaojian Wang, Kiana Aran, Xuli Feng, Carlo Lo Sterzo, Richard Tang, Nithya Lingampalli, Hyun Jin Kim & Niren Murthy. (2015) In vivo delivery of transcription factors with multifunctional oligonucleotides. Nature Materials 14:7, pages 701-706.
Crossref
Crossref
Sonia Trombino, Teresa Ferrarelli & Roberta Cassano. (2014) A New Pro-Prodrug Aminoacid-Based for Trans-Ferulic Acid and Silybin Intestinal Release. Journal of Functional Biomaterials 5:3, pages 99-110.
Crossref
Crossref
Devyani Dube, Madhu Gupta & Suresh P. Vyas. (2012) Nanocarriers for Drug Targeting to Macrophages: Emerging Options for a Therapeutic Need. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 82:S1, pages 151-165.
Crossref
Crossref